Dr. Sahin gave a talk on “Targeting LOX in chemoresistance and developing novel LOX inhibitors” at the ACS Mini Symposium

Dr. Sahin co-organized a Mini Symposium with Dr. Taru Muranen (Dana-Farber Cancer Institute) and Rebeca San Martin (University of Tennessee, Knoxville) which was hosted by Joe Cotter from the American Cancer Society – February 17, 2021. The Mini Symposium was on “Tumor microenvironment in the context of drug resistance and metastasis”. Dr. Sahin Presented our work targeting ECM remodeler LOX to overcome chemoresistance in TNBC and developing novel LOX inhibitors. This virtual meeting hosted more than 100 attendees.